Title |
Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database
|
---|---|
Published in |
European Journal of Clinical Pharmacology, June 2014
|
DOI | 10.1007/s00228-014-1707-9 |
Pubmed ID | |
Authors |
François Montastruc, Cannelle Duguet, Vanessa Rousseau, Haleh Bagheri, Jean-Louis Montastruc |
Abstract |
Lists of potentially inappropriate medications (PIM) in the elderly were developed in order to identify patients and/or drugs at risk of adverse drug reactions (ADRs) or inefficacy. However, the relationship between PIMs and ADRs remains discussed. We hypothesized that PIM use is associated with more ADRs than other prescriptions. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 40% |
Unknown | 6 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 70% |
Practitioners (doctors, other healthcare professionals) | 3 | 30% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 3% |
Finland | 1 | 1% |
Unknown | 67 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 20% |
Student > Master | 11 | 16% |
Student > Doctoral Student | 8 | 11% |
Student > Bachelor | 8 | 11% |
Student > Postgraduate | 7 | 10% |
Other | 13 | 19% |
Unknown | 9 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 40% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 21% |
Psychology | 4 | 6% |
Agricultural and Biological Sciences | 3 | 4% |
Nursing and Health Professions | 2 | 3% |
Other | 6 | 9% |
Unknown | 12 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2015.
All research outputs
#5,406,469
of 22,757,090 outputs
Outputs from European Journal of Clinical Pharmacology
#626
of 2,554 outputs
Outputs of similar age
#50,529
of 228,190 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#7
of 26 outputs
Altmetric has tracked 22,757,090 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,554 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,190 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.